News

Alembic Pharmaceuticals completes USFDA RRA for its bioequivalence facility

The RRA was conducted from 22nd August, 2022 to 26th August, 2022.

Alembic Pharmaceuticals Limited has successfully completed the US Food and Drug Administration (USFDA) Remote Regulatory Assessment (RRA) for its Bioequivalence Facility, Bio-analytical division, located at Vadodara, without any observations.

The RRA was conducted from 22nd August, 2022 to 26th August, 2022.

Upcoming E-conference

Other Related stories

Cipla invests additional Rs. 26 crore in Achira

Granules India posts Q4 FY24 consolidated PAT at Rs. 129.64 Cr

Ind-Swift posts Q4 FY24 consolidated PAT at Rs. 37.53 Cr

Interviews

Capex comm

Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India

Our focus

Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries

We have co

We have consistently expanded our business in India: Vinod Paremal, President & MD, Evonik, India Region

Appointments

Gland Pharma appoints Satnam Singh Loomba as COO

Gland Pharma appoints Satnam Singh Loomba as COO

Merck India appoints Dhananjay Singh as MD Merck Life Science in India

Merck India appoints Dhananjay Singh as MD Merck Life Science in India

Lupin appoints Dr. Ranjana Pathak as Chief Quality Officer

Lupin appoints Dr. Ranjana Pathak as Chief Quality Officer

Startup

Pfizer joins hands with NIPER (Ahmedabad) to support Healthcare Innovation in India

Pfizer joins hands with NIPER (Ahmedabad) to support Healthcare Innovation in India

DPIIT recognises 1, 17,254 startups as on Dec 2023

DPIIT recognises 1, 17,254 startups as on Dec 2023

SigTuple’s AI100 with Shonit receives USFDA 510(k) clearance

SigTuple’s AI100 with Shonit receives USFDA 510(k) clearance

Digitization

Wipro to implement Independent Health’s Medicare prescription payment plan platform

Wipro to implement Independent Health’s Medicare prescription payment plan platform

Lonza launches AI-enabled Route Scouting Service to accelerate small molecule development

Lonza launches AI-enabled Route Scouting Service to accelerate small molecule development

Parexel and Palantir to accelerate clinical data delivery and power clinical outcomes for patients

Parexel and Palantir to accelerate clinical data delivery and power clinical outcomes for patients

Latest Stories

Cipla invests additional Rs. 26 crore in Achira

Granules India posts Q4 FY24 consolidated PAT at Rs. 129.64 Cr

Ind-Swift posts Q4 FY24 consolidated PAT at Rs. 37.53 Cr

Bayer starts Phase I study with novel targeted radionuclide therapy in advanced metastatic prostate cancer

IOL Chemicals and Pharmaceuticals posts Q4 FY24 consolidated PAT at Rs. 27.62 Cr

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Opinion

Defending Public Health: Strategies to safeguard pharmaceutical quality: Raheel Shah, Business Development Director, BDR Pharmaceuticals

Defending Public Health: Strategies to safeguard pharmaceutical quality: Raheel Shah, Business Development Director, BDR Pharmaceuticals

Advanced Treatments for Brain Tumors: Secure Procedures Available

Advanced Treatments for Brain Tumors: Secure Procedures Available

Interviews

Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India

Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India

Dr. R. Ananthanarayanan CEO, Sajjan India

Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries

Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries

Dr. Aman Desai Promoter and Whole Time Director, Aether Industries

We have consistently expanded our business in India: Vinod Paremal, President & MD, Evonik, India Region

We have consistently expanded our business in India: Vinod Paremal, President & MD, Evonik, India Region

Vinod Paremal President & MD, Evonik, India Region

Packaging

Coveris invests over €8 million in production capacity

Coveris invests over €8 million in production capacity

Sulzer launches new biodegradable polymer

Sulzer launches new biodegradable polymer

Solvay launches new PVDC coating solution for more sustainable pharma blister films

Solvay launches new PVDC coating solution for more sustainable pharma blister films